ACTIVE HALF-LIFE
5-7 Days
CLASSIFICATION
Anabolic Steroid
DOSAGE
Recommended for Men: 500-1500 mg/week
ACNE
Possible
WATER RETENTION
Yes
HBR
Potentially
HEPATOTOXICITY
Yes
AROMATIZATION
Yes
CARRIER OIL
Grapeseed Oil
MANUFACTURER
Pharmacom Labs - US
LAB TEST
Refer to Documentation
WAREHOUSE
USA Warehouse 4
SUBSTANCE
Drostanolone Enanthate, Testosterone Enanthate, Trenbolone Enanthate
Introducing PHARMAMIX 2, the ultimate blend for serious athletes looking to elevate their performance! With our long ester formulations, you can experience sustained results without compromise.
PHARMAMIX 6 - Unleash Your True Genetic Potential!
Crafted by Pharmacom Labs, these mixes are the culmination of nearly a decade of expertise and a keen understanding of our customers' needs. Each formulation is meticulously tailored to achieve specific goals?be it cutting, bulking, or enhancing pre-workout performance?while ensuring the biological compatibility of powerful compounds and their anabolic/androgenic properties.
At the core of all Pharmacom Labs? mixes is testosterone in various ester forms. It?s important to remember that any exogenous hormones or steroids, whether taken orally or via injection, can impact the HPTA (hypothalamic-pituitary-testicular axis), potentially leading to a decrease in your body?s natural testosterone output. Testosterone is vital for male health and influences a multitude of bodily functions; insufficient levels can result in unwanted side effects.
Our mixes are designed to be effective standalone stacks, ensuring you achieve maximum results with an optimal balance of active ingredients, often negating the need for additional products. Plus, purchasing a mix is a more economical option compared to buying each ingredient individually at the same dosage.
WARNING: If you are using a highly concentrated product for the first time, we recommend starting with just ? ml to assess your body's response and minimize potential side effects, such as post-injection pain (PIP), elevated body temperature, lumps, and more.
